Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Shanghai EpimAb Biotherapeutics Co., Ltd.
Scientific Title
A First-in-human, Phase I/II, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of EMB-06 in Patients With Recurrent or Refractory Multiple Myeloma